| 1 |
29124793 | Evidence for allosteric effects on p53 oligomerization induced by phosphorylation. | 2018 Feb |
1 |
| 2 |
26417293 | Mutant p53 protein expression and antioxidant status deficiency in breast cancer. | 2014 |
1 |
| 3 |
22982566 | Hypoxia, Mn-SOD and H(2)O(2) regulate p53 reactivation and PRIMA-1 toxicity irrespective of p53 status in human breast cancer cells. | 2012 Dec 15 |
2 |
| 4 |
21396347 | FAT10 modifies p53 and upregulates its transcriptional activity. | 2011 May 15 |
3 |
| 5 |
21508668 | Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs. | 2011 May 15 |
1 |
| 6 |
14639618 | An in vitro model to optimize dose scheduling of multimodal radioimmunotherapy and chemotherapy: effects of p53 expression. | 2004 Jan 10 |
1 |
| 7 |
11238924 | A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. | 2001 Mar |
2 |
| 8 |
11555596 | Isolation of human antibodies against the central DNA binding domain of p53 from an individual with colorectal cancer using antibody phage display. | 2001 Sep |
1 |
| 9 |
10071687 | P53 overexpression and proliferative potential in malignant meningiomas. | 1999 |
1 |
| 10 |
7530828 | Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein. | 1995 Jan 19 |
1 |
| 11 |
7537340 | Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions. | 1995 Apr 21 |
1 |
| 12 |
7655736 | Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors. | 1995 |
1 |
| 13 |
8061893 | Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. | 1994 Jun |
3 |
| 14 |
8089212 | Antibody for detecting p53 protein by immunohistochemistry in normal tissues. | 1994 Jul |
1 |
| 15 |
8275497 | The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis. | 1994 Jan 15 |
2 |
| 16 |
8302577 | DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. | 1994 Jan |
4 |
| 17 |
8217600 | Expression of different conformations of p53 in the blast cells of acute myeloblastic leukaemia is related to in vitro growth characteristics. | 1993 Nov |
3 |
| 18 |
8418091 | Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone. | 1993 |
1 |
| 19 |
1562724 | Constitutive expression of p53 protein in enriched normal human marrow blast cell populations. | 1992 Apr 15 |
1 |
| 20 |
1567424 | hsp70 binds specifically to a peptide derived from the highly conserved domain (I) region of p53. | 1992 Apr 15 |
2 |
| 21 |
1630824 | Altered conformation of the p53 protein in myeloid leukemia cells and mitogen-stimulated normal blood cells. | 1992 Aug |
3 |
| 22 |
1685017 | Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer. | 1991 Dec |
2 |
| 23 |
1923530 | Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240. | 1991 Sep |
2 |
| 24 |
1691710 | Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. | 1990 May |
5 |